Novavax announces bf vaccine using Indonesian mutation

[Binkerbear]

9:39AM Novavax announces it succeeds in making vaccine to protect against new mutation of avian influenza (NVAX) 3.59 +0.15 : Co said its scientists have succeeded in making a vaccine candidate designed to protect against the H5N1 clade 2 influenza virus. Pre-clinical testing of the vaccine has already started. "We believe this is the first vaccine to be made that targets the H5N1 clade 2 virus isolated from people in Indonesia who have been infected with this mutated version of avian influenza... This is a very significant milestone for Novavax and our proprietary virus-like particle vaccine technology. This demonstrates how rapidly we can respond by making a vaccine to protect against emerging pathogens worldwide, compared to older egg-based manufacturing methods." Pre-clinical testing of the H5N1 clade 2 vaccine has already been initiated and is likely to take several months. "Once we collect and analyze results of our pre-clinical tests, we will then be in a position to take this timely vaccine into human clinical trials."